Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Group Calls For Official Health App Assessments As Google And Apple Act As ‘De Facto Regulators’

Executive Summary

The regulation of health and wellness apps in the EU and beyond should involve certification from a third-party organization, while proposed legislation on health data must align with the Medical Device Regulation, warns European Commission group Label2Enable.

You may also be interested in...



UK Should Introduce ‘NHS Accreditation’ Scheme For Health Apps, Says Report

Health apps should be subject to a comprehensive accreditation scheme in the UK that assesses products for their clinical efficacy, security and cost, according to a new report by MPs on digital transformation in the NHS.

MedTech Europe Urges EU To Support European Health Data Space Proposal

The European Commission’s proposed Regulation on the European Health Data Space has been broadly met with optimism by MedTech Europe. While some fine-tuning is needed, the trade body believes the initiative will help align health data across the EU.

First Of Its Kind: UK Hospital To Apply For ADA-SCID Gene Therapy Approval

Great Ormond Street Hospital is piloting a new approach to gene therapy delivery in which it will submit a marketing authorization application to the UK regulator for a lentiviral gene therapy used to treat ADA-SCID, a rare disease.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147543

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel